| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-48 |
Sentence |
denotes |
COVID-19 Comes 40 Years After AIDS - Any Lesson? |
| T1 |
0-48 |
Sentence |
denotes |
COVID-19 Comes 40 Years After AIDS - Any Lesson? |
| T2 |
49-202 |
Sentence |
denotes |
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has hit health-care systems and societies in an unprecedented manner. |
| T2 |
49-202 |
Sentence |
denotes |
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has hit health-care systems and societies in an unprecedented manner. |
| T3 |
203-356 |
Sentence |
denotes |
In 1981, the first cases of AIDS were reported and wide diagnostic testing helped to characterize high-risk groups and the global burden of the epidemic. |
| T3 |
203-356 |
Sentence |
denotes |
In 1981, the first cases of AIDS were reported and wide diagnostic testing helped to characterize high-risk groups and the global burden of the epidemic. |
| T4 |
357-501 |
Sentence |
denotes |
With Coronavirus Disease (COVID)-19, everything has happened too fast and both cases and fatalities are huge but still uncertain in most places. |
| T4 |
357-501 |
Sentence |
denotes |
With Coronavirus Disease (COVID)-19, everything has happened too fast and both cases and fatalities are huge but still uncertain in most places. |
| T5 |
502-613 |
Sentence |
denotes |
Diagnostic testing of active and past SARS-CoV-2 infections needs to expand rapidly, ideally using rapid tests. |
| T5 |
502-613 |
Sentence |
denotes |
Diagnostic testing of active and past SARS-CoV-2 infections needs to expand rapidly, ideally using rapid tests. |
| T6 |
614-770 |
Sentence |
denotes |
COVID-19 deaths are highly concentrated in the elderly population, with a large proportion of fatalities being "with" rather than "by" SARS-CoV-2 infection. |
| T6 |
614-770 |
Sentence |
denotes |
COVID-19 deaths are highly concentrated in the elderly population, with a large proportion of fatalities being "with" rather than "by" SARS-CoV-2 infection. |
| T7 |
771-851 |
Sentence |
denotes |
They are often the result of inadequate health care due to overwhelming demands. |
| T7 |
771-851 |
Sentence |
denotes |
They are often the result of inadequate health care due to overwhelming demands. |
| T8 |
852-915 |
Sentence |
denotes |
To date, there is no specific therapy for SARS-CoV-2 infection. |
| T8 |
852-915 |
Sentence |
denotes |
To date, there is no specific therapy for SARS-CoV-2 infection. |
| T9 |
916-1018 |
Sentence |
denotes |
Several antivirals are being tested clinically, including remdesivir, at this time the most promising. |
| T9 |
916-1018 |
Sentence |
denotes |
Several antivirals are being tested clinically, including remdesivir, at this time the most promising. |
| T10 |
1019-1127 |
Sentence |
denotes |
For others such as lopinavir/ritonavir, neither significant virological nor clinical benefit has been shown. |
| T10 |
1019-1127 |
Sentence |
denotes |
For others such as lopinavir/ritonavir, neither significant virological nor clinical benefit has been shown. |
| T11 |
1128-1322 |
Sentence |
denotes |
Given the characteristic pulmonary cytokine storm underlying the pathogenic mechanism of severe COVID-19 pneumonia and acute respiratory distress, antiinflammatory agents are being investigated. |
| T11 |
1128-1322 |
Sentence |
denotes |
Given the characteristic pulmonary cytokine storm underlying the pathogenic mechanism of severe COVID-19 pneumonia and acute respiratory distress, antiinflammatory agents are being investigated. |
| T12 |
1323-1391 |
Sentence |
denotes |
The benefit of orticosteroids, hydroxychloroquine, etc., is limited. |
| T12 |
1323-1391 |
Sentence |
denotes |
The benefit of orticosteroids, hydroxychloroquine, etc., is limited. |
| T13 |
1392-1553 |
Sentence |
denotes |
Monoclonal antibodies targeting different pro-inflammatory cytokines, such as tocilizumab, an anti-interleukin 6 agent, are being tried with encouraging results. |
| T13 |
1392-1553 |
Sentence |
denotes |
Monoclonal antibodies targeting different pro-inflammatory cytokines, such as tocilizumab, an anti-interleukin 6 agent, are being tried with encouraging results. |
| T14 |
1554-1650 |
Sentence |
denotes |
Ultimately a protective vaccine will be the best response for controlling the COVID-19 pandemic. |
| T14 |
1554-1650 |
Sentence |
denotes |
Ultimately a protective vaccine will be the best response for controlling the COVID-19 pandemic. |